Due to the rising prevalence and significant burden of Alzheimer’s disease there is a critical need for continuing education aimed at bridging existing gaps in clinician knowledge, competence, and performance concerning novel and emerging amyloid-targeting therapies (ATTs), especially in the …
Racism has historically, systemically, and continuously developed and fueled discriminatory practices and rhetoric against racial and ethnic underserved individuals in the United States. Those practices remain embedded in society and institutions, including the healthcare system. Given the long-standing history and …
Data from recent clinical trials for first-line combination options using immunotherapies for ovarian cancer (OC) can be challenging for clinicians with no experience selecting patients for combinatorial treatment approaches or using combination therapies for their patients. During this podcast, Drs. …
The 2016 Guideline for Prescribing Opioids for Chronic Pain, produced by the Centers for Disease Control and Prevention (CDC), effectively changed opioid prescribing with a decrease in the number of high-dose opioid prescriptions. Since then, however, there has been misapplication …
The treatment landscape for psoriasis (PsO) and psoriatic arthritis (PsA) is evolving, yet many novel approaches have limitations. Several Janus kinase inhibitors (JAKis) have indications for only one of the two conditions; others carry black box warnings from the U.S. …
Psoriatic arthritis (PsA) diagnosis and management have been directed by three main sets of guidelines: the American College of Rheumatology (ACR) guidelines, the European Alliance of Associations for Rheumatology (EULAR) guidelines, and the Group for Research and Assessment of Psoriasis …
Psoriasis (PsO) is a disease in which rough, scaly patches of skin develop on a significant portion of the body, most commonly the knees, elbows, trunk, and scalp. This condition has daily negative implications for quality of life that include …
Clinicians treating patients with T2D need to know how to choose and optimally use incretin therapies that have activity against common comorbidities in T2D, including obesity and CVD. Over the past decade there have been several new classes of drugs …
Recent data has led to a debate of the most effective maintenance strategy for advanced OC. Emerging data utilizing novel approaches to maintenance both further complicates the debate and sheds new light on novel effective strategies for maintenance therapy for …